ROYCE & ASSOCIATES LP - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$6,977,000
-15.2%
132,058
-1.7%
0.08%
-17.6%
Q2 2020$8,232,000
+4.4%
134,335
-3.6%
0.09%
-15.0%
Q1 2020$7,883,000
-19.2%
139,344
-18.7%
0.11%
+23.0%
Q4 2019$9,753,000
-9.8%
171,294
-15.3%
0.09%
-13.0%
Q3 2019$10,818,000
+342.8%
202,137
+394.0%
0.10%
+354.5%
Q2 2019$2,443,000
-4.1%
40,922
+0.1%
0.02%0.0%
Q1 2019$2,548,000
-19.4%
40,876
-21.6%
0.02%
-21.4%
Q4 2018$3,160,000
-8.6%
52,141
-11.8%
0.03%
+16.7%
Q3 2018$3,456,000
+19.8%
59,085
-8.2%
0.02%
+20.0%
Q2 2018$2,886,000
+1.3%
64,339
+0.2%
0.02%0.0%
Q1 2018$2,848,000
+36.9%
64,232
+33.7%
0.02%
+42.9%
Q4 2017$2,081,000
+13.2%
48,038
+21.6%
0.01%
+16.7%
Q3 2017$1,838,000
-5.8%
39,517
+0.3%
0.01%
-7.7%
Q2 2017$1,951,000
-9.6%
39,4000.0%0.01%
-7.1%
Q1 2017$2,159,000
-13.9%
39,400
-12.4%
0.01%
-12.5%
Q4 2016$2,507,000
-27.4%
45,000
-40.5%
0.02%
-30.4%
Q3 2016$3,453,000
-9.1%
75,600
-20.5%
0.02%
-8.0%
Q2 2016$3,798,000
+46.2%
95,100
+27.5%
0.02%
+56.2%
Q1 2016$2,597,000
+30.8%
74,590
+61.5%
0.02%
+33.3%
Q4 2015$1,985,000
-1.3%
46,2000.0%0.01%
+9.1%
Q3 2015$2,012,000
-15.6%
46,2000.0%0.01%
+10.0%
Q2 2015$2,384,000
+25.3%
46,200
-4.9%
0.01%
+42.9%
Q1 2015$1,903,000
+1.4%
48,6000.0%0.01%0.0%
Q4 2014$1,877,000
-38.6%
48,600
-43.9%
0.01%
-30.0%
Q3 2014$3,057,000
+13.4%
86,600
-13.4%
0.01%
+25.0%
Q2 2014$2,696,000
+4.0%
100,0000.0%0.01%0.0%
Q1 2014$2,592,000
+19.6%
100,0000.0%0.01%
+33.3%
Q4 2013$2,167,000
+11.3%
100,0000.0%0.01%0.0%
Q3 2013$1,947,000
+24.8%
100,0000.0%0.01%
+20.0%
Q2 2013$1,560,000100,0000.01%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2020
NameSharesValueWeighting ↓
UBS ASSET MANAGEMENT AMERICAS INC 2,300$203,550,0000.00%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders